AT7519, a cyclin-dependent kinase inhibitor, exerts its effects by transcriptional inhibition in leukemia cell lines and patient samples
- Matthew S. Squires
- , Laurence Cooke
- , Victoria Lock
- , Wenqing Qi
- , E. Jonathan Lewis
- , Neil T. Thompson
- , John F. Lyons
- , Daruka Mahadevan
Research output: Contribution to journal › Article › peer-review
48
Link opens in a new tab
Scopus
citations